Tiger Brokers

热门话题-Shattuck Labs因7500万美元的股票出售而股价下跌

路透中文
Jun 10
热门话题-<a href="https://laohu8.com/S/STTK">Shattuck Labs</a>因7500万美元的股票出售而股价下跌

6月10日 - ** 生物技术公司Shattuck Labs（STTK.O）周三盘前股价下跌5.6%，报4.03美元，此前该公司定价完成7500万美元的后续融资

** 这家专注于炎症和免疫介导性疾病治疗的开发商于周三早间宣布， (link) 已售出约1090万股股票，并以每股4美元的价格预付认股权证，用于购买约790万股股票

** 发行价较周二收盘价折让6.3%

** 根据招股说明书，STTK计划将本次发行净收益用于推进既定临床试验、开发及推进其他候选产品等用途 (link)

** 联席簿记管理人为Leerink Partners、摩根大通、Piper Sandler及Cantor Fitzgerald

** 总部位于得克萨斯州奥斯汀的STTK目前流通股约为7670万股

** STTK股价周二上涨9.5%，年内累计涨幅扩大至17%

** 据LSEG数据显示，8位分析师均对该股持乐观态度，其中2位给予“强烈买入”评级；目标价中位数为17美元

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10